Citations 1
Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders
Darakjian, Ashley A. , Bhutani, Mira, Fairweather, DeLisa , Kocsis, S , Fliess, Jessica J. , Khatib, Sami , Weigel, Gabe J , McCabe, Elizabeth J , Balamurugan, Varsini, Perona, Evan E , Gehin, Jessica M. , Jain, Angita , Sledge, Hanna, Hodge, David O. , Rozen, Todd D. , Soyer, Ozan, Cheung, Joseph , Shirey, David, Gajarawala, Shilpa , Munipalli, Bala , Weigel, G. , Kocsis, S Christian, Whelan, Emily R. , Rozen, Todd D , Farraye, Francis A , Cheung, Joseph , Grach, Stephanie L , Gajarawala, Shilpa , Munipalli, Bala , Shufelt, Chrisandra L , Knight, Dacre R T , Bruno, Katelyn A , Fairweather, DeLisa , Bhutani, Mira, Farraye, Francis A. , Soyer, Ozan, Grach, Stephanie L. , Shufelt, Chrisandra , Bruno, Katelyn A.
Rheumatology Advances in Practice | December 10, 2024 | Volume: 8 | Issue: 4 | Pages: No page available
Abstract Objectives Patients with hypermobile Ehlers–Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) experience a wide array of symptoms and system disorders. This study aimed to identify whether differences occurred in 115 self-reported symptoms and comorbidities in patients diagnosed with hEDS or HSD. Methods In this study we analysed self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS, HSD or no hypermobile conditions. Results From 1 November 2019 to 7 March 2024, the EDS Clinic saw 2088 patients. Using the 2017 diagnostic criteria, 66.5% were diagnosed with HSD (n = 1389), 20.3% with hEDS (n = 423), 10.6% with historic HSD (H-HSD) or localized HSD (L-HSD) (n = 256) (hypermobile controls) and 2.6% were not diagnosed with hEDS, HSD, H-HSD or L-HSD (n = 55) (controls). Symptoms/comorbidities that occurred with high prevalence in both hEDS and HSD included joint pain (hEDS 82.0%, HSD 88.9%), allergy (hEDS 77.0%, HSD 77.0%), subluxations (hEDS 71.2%, HSD 72.6%), brain fog (hEDS 70.0%, HSD 74.7%), headache (hEDS 68.1%, HSD 69.1%), anxiety (hEDS 60.3%, HSD 69.3%), depression (hEDS 52.2%, HSD 58.0%), migraine (hEDS 53.7%, HSD 52.5%), nausea (hEDS 54.6%, HSD 59.5%) and constipation (hEDS 53.0%, HSD 57.2%). In contrast, 9/115 (8%) symptoms/comorbidities were self-reported significantly more often in hEDS but 42/115 (37%) in HSD. hEDS patients reported more symptoms that suggest a defect in collagen, such as dislocation, hernias and rectal prolapse, while HSD patients reported more joint, muscle, allergy, neurological, gastrointestinal, sleep and psychological symptoms/comorbidities. Conclusion Although we found an overlap in some symptoms and comorbidities self-reported by hEDS/HSD patients, such as allergy/atopy, headache/migraine and gastrointestinal symptoms, our findings suggest key differences exist between the two diagnoses, suggesting that hEDS and HSD may be distinct conditions.